Signs of inflammatory bowel disease (IBD ... the long data collection period involved changes in treatment models for IBD and C difficile infection, which may have influenced the results.

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

Investigators at Pennsylvania State University have described a novel approach to combat Clostridioides difficile infection ...

A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides difficile (C. difficile) infection, particularly those resistant to antibiotics.